<bill session="110" type="sr" number="454" updated="2013-07-19T22:16:57-04:00">
  <state datetime="2008-02-14">REFERRED</state>
  <status>
    <introduced datetime="2008-02-14"/>
  </status>
  <introduced datetime="2008-02-14"/>
  <titles>
    <title as="introduced" type="official">A resolution designating the month of March 2008 as "MRSA Awareness Month".</title>
  </titles>
  <sponsor id="300038"/>
  <cosponsors>
    <cosponsor id="400050" joined="2008-02-14"/>
    <cosponsor id="412246" joined="2008-02-25"/>
    <cosponsor id="300052" joined="2008-02-14"/>
    <cosponsor id="400272" joined="2008-02-14"/>
    <cosponsor id="300092" joined="2008-02-14"/>
    <cosponsor id="412247" joined="2008-02-25"/>
  </cosponsors>
  <actions>
    <action datetime="2008-02-14">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S1072-1073"/>
    </action>
    <action state="REFERRED" datetime="2008-02-14">
      <text>Referred to the Committee on the Judiciary.</text>
      <reference ref="CR S1072" label="text of measure as introduced"/>
    </action>
  </actions>
  <committees>
    <committee code="SSJU" name="Senate Judiciary" activity="Referral, In Committee"/>
  </committees>
  <relatedbills>
    <bill relation="unknown" session="110" type="hr" number="988"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Antibiotics"/>
    <term name="Commemorations"/>
    <term name="Communicable diseases"/>
    <term name="Drug resistance in microorganisms"/>
    <term name="Health education"/>
    <term name="Hospitals"/>
    <term name="Medical research"/>
    <term name="Pharmaceutical research"/>
    <term name="Preventive medicine"/>
    <term name="Science, technology, communications"/>
    <term name="Special months"/>
  </subjects>
  <amendments/>
  <summary>2/14/2008--Introduced.
Designates March 2008 as MRSA Awareness Month.Recognizes: (1) the need to apply what is already known about reducing the transmission of infections in hospitals, effectively using diagnostics, and ensuring appropriate use of antibiotics to meet patient and public health needs; (2) the need to pursue operational research to find the best ways of preventing hospital- and community-acquired Methicillin-resistant Staphylococcus aureus (MRSA) and developing new antibiotics for improving care for MRSA patients; and (3) the importance of raising awareness of MRSA and methods of preventing MRSA infections.Expresses support for the work of advocates, healthcare practitioners, and science-based experts in educating, supporting, and providing hope for individuals and their families affected by community and healthcare associated infections.</summary>
</bill>
